ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Spatially Organized Human Ovarian Spheroids Instruct Endometrial Morphogenesis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The human ovarian-endometrial axis operates through coordinated, dynamic endocrine signaling that cannot be faithfully reproduced by static hormone supplementation. While endometrial organoids (EMOs) respond to exogenous estradiol and progesterone, whether a spatially organized human ovarian endocrine unit can instruct epithelial morphogenesis through physiologically integrated signaling remains unknown. Here, we engineered a multilayered human follicle-like spheroid composed of primary granulosa cells and stromal-derived theca-like cells (SPHEGaT), recreating architectural and steroidogenic features of the ovarian follicle. These constructs generated sustained biologically active concentrations of estradiol and progesterone while maintaining high viability and low hypoxic burden. When co-cultured with EMOs, SPHEGaTs induced progressive epithelial remodeling characterized by folding morphogenesis, increased progesterone receptor expression, and upregulation of secretory/progesterone-responsive genes including PAEP, SPP1 and HSD17B2. Strikingly, partial steroid depletion did not abolish organoid folding, whereas static supplementation with exogenous estradiol and progesterone failed to restore the differentiation phenotype. These findings suggest that endometrial remodeling is influenced not merely by hormone concentration, but also by additional signaling cues present within the SPHEGaT-derived microenvironment. Together, this work establishes a human 3D platform in which integrated ovarian-derived signaling supports epithelial morphogenesis, providing new framework for studying ovarian-endometrial communication and highlighting the limitations of hormone-only models in reproductive bioengineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.